NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.6501
Delayed Data
As of Jul 02
 +0.0201 / +3.19%
Today’s Change
0.42
Today|||52-Week Range
1.30
+3.19%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.90, with a high estimate of 2.00 and a low estimate of 1.50. The median estimate represents a +192.26% increase from the last price of 0.65.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$628.0K
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 29.63%
 
 
 
 
 
 
Growthannually 23.65%
 
 
 
 
 
 

Sales

Growthquarterly 16.73%
 
 
 
 
 
 
Growthannually 364.91%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account